SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirms strong quarterly results and upbeat outlook sparked a rally and analyst upgrades, but shares then sharply reversed. Traders are split between viewing the pullback as profit-taking after the earnings surge and worrying about valuation, interest rates, and consumer credit quality; some also question how much of the reported profit came from a one-time benefit.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLakes pending FDA acceptance and review-timeline decision for its sonelokimab BLA in hidradenitis suppurativa is the main focus, with traders debating the odds of priority review and a potential stock catalyst. Optimism about the drugs prospects is offset by concerns about regulatory risk, competition, and whether MoonLake can commercialize on its own without further financing or a partnership.

ExxonMobil Holdings Corp. is an international energy and petrochemical company, which creates solutions that improve quality of life and meets society’s evolving needs. The company is headquartered in Spring, TX.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Exxons quarterly earnings beat, powered by unusually strong refining and fuel margins that outweighed weaker upstream results, is the dominant catalyst behind attention. Traders welcomed the results and shareholder returns, while some questioned whether refining profits can last and viewed the stocks run-up as stretched.

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,559,996,383.70523. The last known price of Dogecoin is 0.07552377 USD and is down -0.48 over the last 24 hours. It is currently trading on 1543 active market(s) with $337,365,256.17 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

DOGEs weak, range-bound trading around the 8-cent area dominates discussion, with traders pointing to repeated failures to reclaim that level and bearish or consolidation chart setups. Dip-buyers and long-term holders remain hopeful, while frustrated traders cite further downside and lingering losses; no specific confirmed catalyst stands out.

XPeng, Inc. is a global physical AI company, which engages in bringing artificial intelligence into the physical world to reshape future mobility and smart living. It developed a full-stack physical AI architecture spanning Turing AI chips, world foundation models, and integrated software and hardware applications. The firm's product portfolio includes smart EVs, robotaxis, and humanoid robots. The company's sales and services drives continuous technological innovation and fosters an open physical AI ecosystem, making life smarter, safer, and better for users worldwide. XPeng, Inc. was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPengs record October deliveries and rapid overseas growth are drawing attention, but traders are weighing the sales momentum against the pace needed to meet Q4 goals and concerns about margins amid intense China EV competition. The strong operating updates have not eased frustration over the share-price slide or doubts about profitability.

Chainlink (LINK) is a cryptocurrency launched in 2017and operates on the Ethereum platform. Chainlink has a current supply of 1,000,000,000 with 748,099,970.42488396 in circulation. The last known price of Chainlink is 11.67852871 USD and is up 2.18 over the last 24 hours. It is currently trading on 2313 active market(s) with $325,834,414.23 traded over the last 24 hours. More information can be found at https://chain.link/.

ChainLink

LINKs sharp rebound and repeated tests of resistance are driving attention, alongside optimism about Chainlinks institutional and tokenization integrations, including CCIP updates. Bulls view adoption and recent momentum as reasons to accumulate, while skeptics point to weak follow-through, sell pressure, and uncertainty over how network usage benefits the token.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX is drawing attention after a sharp breakout to a fresh 52-week high ahead of an anticipated Q3 update, with traders also pointing to heavy call buying and possible short covering. Buyout speculation is adding to the bullish chatter, but remains unconfirmed, and some traders caution that the run-up may leave the stock vulnerable if results disappoint.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

Volatile crude prices tied to Iran and Strait of Hormuz disruption and ceasefire headlines are driving attention to OXY. Traders are split between expecting supply risks to support the oil producer and worrying that de-escalation, falling crude, and the stocks lagging response will weigh on shares.

OFFICIAL TRUMP (TRUMP) is a cryptocurrency and operates on the Solana platform. OFFICIAL TRUMP has a current supply of 999,998,811.032761 with 281,866,747.320393 in circulation. The last known price of OFFICIAL TRUMP is 1.57555883 USD and is down -1.93 over the last 24 hours. It is currently trading on 744 active market(s) with $126,884,732.61 traded over the last 24 hours. More information can be found at https://gettrumpmemes.com/.

Trump For President

TRUMP memecoin discussion is dominated by its steep decline and accusations that holders were left with losses, with traders debating whether election-related speculation could spark another pump or whether the token will keep sliding. A smaller bullish contingent points to accumulating or a possible squeeze, but the broader tone is skeptical.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevrons quarterly earnings beat expectations, with strong refining margins and record U.S. refinery throughput drawing particular attention alongside robust cash generation and debt reduction. Traders largely welcomed the results and the stocks strength, while some questioned whether elevated refining profits and oil prices can persist.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Full Transcript: Valneva Q2 2026 Earnings Call

Valneva (NASDAQ:VALN) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below.
This content is powered by Benzinga APIs. For comprehensive financial data andread more...

VALN Stock Plunges 7% After-Hours As UK Revokes Valneva’s IXCHIQ Authorization In Latest Market Setback

Equity

Valneva said the Medicines and Healthcare products Regulatory Agency withdrew the U.K. authorization for IXCHIQ on Wednesday. 


12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

Valneva (NASDAQ:VALN) shares rose 20.6% to $7.09 during Wednesday's after-market session. The company's market cap stands at $555.6 million.
Profound Medical (NASDAQ:PROF) stock rose 16.98% to $6.64.read more...

Why Did VALN Stock Surge 24% Today?

The European Medicines Agency validated the marketing authorization application for Valneva’s Lyme disease vaccine, which it developed with Pfizer


Pfizer and Valnevas Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for PF-07307405, the companies 6-valent outer surface protein A (OspA)-based Lyme disease vaccine candidate...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN...

Valneva (NASDAQ:VALN) Downgraded by Wall Street Zen to Strong Sell

Wall Street Zen lowered shares of Valneva to a "strong sell" rating in a research report on Saturday...

Valneva (NASDAQ:VALN) Sets New 12-Month Low After Analyst Downgrade

Valneva (NASDAQ:VALN) Reaches New 12-Month Low Following Analyst Downgrade...

Valneva SE Sponsored ADR (NASDAQ:VALN) Given Average Recommendation of "Hold" by Analysts

Shares of Valneva SE Sponsored ADR (NASDAQ:VALN - Get Free Report) have been assigned a consensus recommendation of "Hold" from the five brokerages that are currently covering the company, MarketBeat...

Valneva (NASDAQ:VALN) Cut to "Sell" at The Goldman Sachs Group

The Goldman Sachs Group lowered Valneva from a "neutral" rating to a "sell" rating and set a $4.90 price target on the stock. in a report on Wednesday...

Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. It currently provides three proprietary travel vaccines: IXIARO, DUKORAL, and IXCHIQ. The IXIARO is an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis in adults, adolescents, children, and infants aged two months and older. The DUKORAL is a drinkable vaccine that helps prevent diarrhea caused by heat-labile toxin-producing ETEC, as well as cholera. The IXCHIQ is a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also offers additional vaccines, including VLA1553, VLA15, VLA160, VLA200, VLA1601 and others. Valneva was founded on May 28, 2013 and is headquartered in Saint-Herblain, France.

Valneva SE - ADR

Bullish Sentiment

<ul class="summary-bullets"><li>Licenses in the European Union, Canada, Brazil and other markets where IXCHIQ is sold are unchanged, Valneva said.</li><li>FDA suspended IXCHIQ’s U.S. license in August 2025 over serious adverse events.</li><li>IXCHIQ brought in €8.4 million ($9.4 million) in sales in 2025, up from €3.7 million the year before, against total product sales of €157.9 million and group revenue of €174.7 million.</li></ul>Valneva shares fell as much as 7% in after-hours trading on Wednesday after the company said U.K. regulators had revoked the marketing authorization for its chikungunya vaccine, IXCHIQ, marking another setback for a product that has already lost its U.S. license.<h2 class="st-heading-2">UK License Pulled</h2>Valneva said the Medicines and Healthcare products Regulatory Agency withdrew the U.K. authorization after a further review by the Commission on Human Medicines. The agency looked again at existing safety data. The company said the decision was not tied to any newly identified safety problem."While the Company disagrees with CHM’s and MHRA’s conclusion, Valneva has decided not to appeal the decision, given its immaterial financial and commercial impact," the company said.&nbsp;The revocation applies only in the United Kingdom. Valneva said licenses in the European Union, Canada, Brazil, and other markets where IXCHIQ is sold are unchanged.IXCHIQ is a single-dose shot meant for travelers heading to regions where chikungunya, a mosquito-borne virus that causes fever and joint pain, is common.&nbsp;Britain approved it in February 2025. Use was later restricted for older adults and people with certain health conditions after rare but serious reactions, mostly in elderly patients with underlying illness, were reported worldwide. The company said on Wednesday that it expects no expense related to product recall and only minimal impact on its overall sales revenue, as it has not actively distributed the vaccine in the UK for several months and has no other products in the market.&nbsp;The U.K. exit continues a retreat that began when the FDA suspended IXCHIQ’s U.S. license in August 2025 over serious adverse events. Valneva later withdrew its U.S. applications.<h2 class="st-heading-2">IXCHIQ's Financial Impact On VALN</h2>IXCHIQ brought in €8.4 million in sales in 2025, up from €3.7 million the year before, against total product sales of €157.9 million and group revenue of €174.7 million. Most of that chikungunya revenue came from European launches and doses supplied during an outbreak on the French island of La Réunion.Even so, the vaccine has been a drag. Label limits and the loss of the U.S. market already led Valneva to write off inventory and book contract-termination costs. In August, the company reaffirmed a previously reduced 2026 product-sales outlook of €135 million–€150 million, citing weaker travel-vaccine demand.<h2 class="st-heading-2">How Did VALN Retail Traders React?</h2>On Stocktwits, retail sentiment around VALN stayed within the ‘neutral’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.<a class="mention" data-mention="$VALN" data-symbol-id="VALN" href="https://stocktwits.com/symbol/VALN" target="_blank">VALN stock</a> has dropped 33% year-to-date.Read More: <a href="https://stocktwits.com/news-articles/markets/equity/sedg-stock-slides-after-deutsche-bank-tags-it-a-short-term-sell/cZDvmlSRBZI">SEDG Stock Slides After Deutsche Bank Tags It A Short-Term Sell</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.Exchange Rate: €1 = $1.12

An illustrative image of a person holding a medical syringe and a Covid-19 vaccine vial in front of the the Valneva logo displayed on a screen. On Wednesday, January 12, 2021, in Edmonton, Alberta, Canada. (Photo by Artur Widak/NurPhoto via Getty Images)

Valneva said the Medicines and Healthcare products Regulatory Agency withdrew the U.K. authorization for IXCHIQ on Wednesday. 

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$5.45
Prev Close	$5.71
Open	$5.61
Dividend Yield	0.00%
50-Day Moving Average	$6.18
Beta	0.86
Avg. Volume	30,564.53
PE Ratio	-2.60

52-Week High	$12.18
52-Week Low	$4.75
Market Capitalization	$518.44M
EPS (Annual)	-$1.55
Price to Book	5.57
Revenue Per Employee	$292,457.41

Feed

News

Sentiment

Earnings

Fundamentals

Info

VALN Fundamentals